Symrise AG在2019年持续其有利可图的增长课程,并实现了全年的所有目标。通过收购ADF / IDF,该公司还加强了其在北美的地位,并扩大了其产品组合在宠物食品市场和食品行业的天然产品解决方案中。考虑到投资组合和汇率效应,销售额增加了8.0%至3408万欧元(2018:31.154亿欧元)。因此,Symrise再次成为该行业增长最快的公司之一。这种强大的表现是通过对所有细分和地区的良好需求携带。收益前的收益,税收,折旧和摊销以及收购ADF / IDF(EBITDA(NITDA(NITDA(NITDA))的一次性效果的标准化增加了7.67亿欧元至70720万欧元。
“Symrise AG再次发布了2019年的强劲增长。通过收购ADF / IDF,我们继续在快速增长,高利润的商业领域扩大。我们还在吸引人的宠物食品市场中进一步多样化了我们的产品组合,并扩大了我们的产品在北美的职位。此外,我们投资扩大了我们在年内的能力,并在世界各地推出了新技术。这些有针对性的增长措施结合我们的纪律的成本管理,明确反映在我们的业务发展中最近的宿舍,“Symrise AG首席执行官Heinz-JürgenBertram博士说。“与我们的客户一起,资本市场也有利于我们的表现。股价在2019年增加了42%。我们希望我们的股东今年再次参加我们的成功。在股东大会的年度大会上,执行委员会和监事会将提出股息增加到每股0.95欧元。“
行业领先的销售增长
In the year under review, Symrise benefited from good capacity utilization and strong demand in all segments and regions. Taking portfolio and exchange rate effects into account, Group sales increased by 8.0 % in the reporting period to € 3,407.9 million (2018: € 3,154.0 million). The organic growth rate achieved a clear plus of 5.7 %. As a result, the Group exceeded the average market growth rate in 2019, which was in the 3 to 4 % range according to estimates. The acquisition of the ADF/IDF Group, a leading US supplier of poultry and egg-based protein specialties, completed in November 2019, contributed approximately € 32 million to Group sales.
High profitability despite investments and fluctuating raw material costs
Despite higher expenses, Symrise increased its earnings before interest, taxes, depreciation and amortization as well as normalized for one-time effects resulting from the acquisition of ADF/IDF (EBITDA(N)) by a clear two-digit result of 12.2 % to € 707.2 million (2018: € 630.5 million). The deal resulted in one-time acquisition and integration expenses of € 16.3 million in 2019. The markets for raw materials remained tense, especially in the first half of the year. Notwithstanding the above, Symrise continued to invest in global capacity expansion. Major investment projects included the new manufacturing site in Nantong (China), the expansion of production capacity for menthol and natural extracts in the USA, and for pet food in Colombia and France.
Symrise achieved very strong profitability in the fiscal year 2019 and significantly exceeded the previous year's level, with an EBITDA(N) margin of 20.8 %. As a result, Symrise was once again one of the most profitable companies in the industry.
Normalized net income increased by 10.2 % year-on-year to € 303.5 million (2018: € 275.3 million). This led to an increase in normalized earnings per share to € 2.25 (2018: € 2.12). Against the backdrop of the positive growth in earnings, the Executive Board and Supervisory Board of Symrise AG will propose a dividend of € 0.95 per share at the Annual General Meeting on 6 May 2020 (2018: € 0.90).
Strong cash flow trend
Symrise grew its normalized Business Free Cash flow by 53 % to € 476 million in the year under review (2018: € 312 million). This represents 14.1 % of sales, as compared to 9.9 % in the previous fiscal year. This significant increase can be attributed above all to the strong gain in net income for the period and a below-average rise in working capital.
As at the reporting date, net debt, including pension provisions and similar obligations, had increased to € 2,221.5 million (2018: € 1,893.1 million). On 31 December 2019, the ratio of net debt – including pension provisions and similar obligations – to EBITDA stood at 3.1, and thus showed little change as compared to the previous year's level (31 December 2018: 3.0). The medium-term target corridor for the ratio is 2.0 to 2.5.
The equity ratio increased from 39.5 % to 41.4 % at year-end. Symrise is thus in a very good financial position.
Segment Scent & Care
在香味和护理分部,报告货币的销售额增长了7.2%至1,41910万欧元(2018年:€1324.1百万欧元)。这比有机术语增加了5.6%。特别是在香料划分中看到动态生长,这对细香产品的需求很强。雷竞技下载二维码这反映在精细香料应用中的两位数百分比增长中,在EAME和拉丁美洲最强烈的需求支持。雷竞技下载二维码化妆品成分和芳香分子分子也张贴了收益。
Scent & Care grew its EBITDA by 9.3 % to € 278.0 million (2018: € 254.4 million). The EBITDA margin for the year under review was 19.6 % (2018: 19.2 %).
Segment Flavor
口味销售实现了5.6%的增长€1,257.3 million in reporting currency (2018: € 1,191.1 million). After adjusting for exchange rate effects, the organic growth amounted to 3.8 %. This positive trend was carried by all regions and application areas. Flavor benefited in particular from dynamic demand in Asia/Pacific, where the segment achieved organic growth in the high single-digit percentage range. This was driven by flavorings for applications for sweet and beverage products, above all in Indonesia, Malaysia and China.
EBITDA in this segment increased significantly by 10.1 % in the reporting period to € 268.5 million (2018: € 243.9 million). As a result, the EBITDA margin was an outstanding 21.4 % (2018: 20.5 %).
Segment Nutrition
The Nutrition segment achieved in 2019 a 14.5 % increase in sales to € 731.5 million after sales of € 638.8 million in 2018. This included a total of € 32 million in sales from the ADF/IDF Group. Through the initial consolidation of the Group in November 2019, the fourth quarter showed a remarkably strong sales increase of 28.7 %. The segment also achieved significant organic growth. Once again, this growth was driven by product solutions in Pet Food. The strongest impetus came from North America and Latin America, where growth was in the double-digit percentage range.
规范化为一次性采集和transaction costs, the segment achieved EBITDA of € 160.7 million for the reporting period (2018: € 132.3 million). This represents an increase of 21.5 %. The EBITDA(N) margin also showed healthy growth. It increased to an excellent 22.0 %, as compared to 20.7 % in 2018.
Symrise looks ahead to 2020 with confidence
In 2020, the Company aims to yet again achieve significantly stronger growth than the relevant market for fragrances and flavors as well as cosmetic ingredients, which is projected to grow at a rate of around 4 %. The Company expects all of its segments to grow notably faster than the global market. Assuming raw material costs at their current levels and a stable EUR/USD exchange rate, Symrise currently anticipates an EBITDA margin of over 20 % in all segments for the current fiscal year.
总体而言,随着其全球存在,多样化的投资组合和经过验证的战略,对称相信实现这些增长雄心壮志的良好。该公司计划在未来快速增长,高利润业务领域继续扩大,将有机投资与有针对性的收购相结合。此外,SYMRISE将继续致力于其纪律处分和效率管理。
Symrise believes that it is very well positioned to achieve the targets updated at the beginning of 2019. By 2025, the Company plans to increase its sales from € 5.5 billion to € 6.0 billion by means of organic growth at an annual rate of 5 to 7 % (CAGR), combined with targeted complementary acquisitions. Long-term, Symrise aims to achieve an EBITDA margin within the target corridor of 20 to 23 %.
